Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study

Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study

<p>Abstract</p> <p>Background</p> <p>Chemokine and chemokine receptors play an essential role in tumorigenesis. Although chemokine-associated single nucleotide polymorphisms (SNPs) are associated with various cancers, their impact on prostate cancer (PCA) among men of A...

Full description

Bibliographic Details
Main Authors: Kidd LaCreis R, Jones Dominique Z, Rogers Erica N, Kidd Nayla C, Beache Sydney, Rudd James E, Ragin Camille, Jackson Maria, McFarlane-Anderson Norma, Tulloch-Reid Marshall, Morrison Seian, Brock Guy N, Barve Shirish S, Kimbro Kevin S
Format: Article
Language:English
Published: BMC 2012-11-01
Series:Hereditary Cancer in Clinical Practice
Subjects:
Prostate cancer
Chemokines
Chemokine receptors
Chemokine ligand 5
Chemokine receptor 5
Single nucleotide polymorphisms
Men of African descent
Online Access:http://www.hccpjournal.com/content/10/1/16

Internet

http://www.hccpjournal.com/content/10/1/16

Similar Items